
501 - 1000 employés
Fondée en 1989
🏥 Santé
🧬 Biotechnologie
💊 Pharmaceutique
Healthcare • Biotechnology • Pharmaceuticals
Ionis Pharmaceuticals, Inc. est une société biopharmaceutique spécialisée dans la découverte et le développement de médicaments ciblant l'ARN et l'ADN pour traiter des maladies graves. L'entreprise utilise la chimie des oligonucleotides et des connaissances génétiques pour développer un portefeuille de traitements dans les domaines de la neurologie, des troubles cardiométaboliques et d'autres domaines à fort besoin, menant des essais cliniques et des collaborations commerciales pour fournir des médicaments aux patients. Ionis met l'accent sur l'innovation scientifique, le plaidoyer pour les patients et la responsabilité d'entreprise dans ses efforts pour transformer la science génétique en thérapies transformatrices.
🕒 il y a 11 jours
🇺🇸 États-Unis – Télétravail
💵 $190 000 - $216 000 / an
⏰ Temps Plein
🟠 Senior
👔 Directeur
👻 Score fantôme 0%
🗣️🇺🇸🇬🇧 Anglais requis
Améliorez vos chances d'obtenir un entretien en vérifiant votre score de CV avant de postuler.

501 - 1000 employés
Fondée en 1989
🏥 Santé
🧬 Biotechnologie
💊 Pharmaceutique
Healthcare • Biotechnology • Pharmaceuticals
Ionis Pharmaceuticals, Inc. est une société biopharmaceutique spécialisée dans la découverte et le développement de médicaments ciblant l'ARN et l'ADN pour traiter des maladies graves. L'entreprise utilise la chimie des oligonucleotides et des connaissances génétiques pour développer un portefeuille de traitements dans les domaines de la neurologie, des troubles cardiométaboliques et d'autres domaines à fort besoin, menant des essais cliniques et des collaborations commerciales pour fournir des médicaments aux patients. Ionis met l'accent sur l'innovation scientifique, le plaidoyer pour les patients et la responsabilité d'entreprise dans ses efforts pour transformer la science génétique en thérapies transformatrices.
• Set strategy and oversee development of access materials, tools, and resources for KAMs • Align KAM communication strategy and tools with institutional, payer, and PBM formulary decision-maker channels • Develop value narratives, core access platforms, training strategies, and pull-through tools • Strategize and lead training and development programs for KAMs, DNAs, FAMs, and Sales • Lead analyses of access landscape, including channel mix, coverage, competitive dynamics, payer unmet need, willingness to pay, and Inflation Reduction Act implications • Serve as access marketing strategic lead in brand planning and guide market access marketing execution for new-to-market therapies • Support access materials and resources for FAMs, DNAs, and Sales • Anticipate market and policy dynamics, synthesize market, payer, and competitive data, identify risks, and recommend mitigation plans • Manage key agency partners, including strategic direction, performance management, and budget stewardship • Provide guidance on navigating materials through the Promotional Review Committee process • Establish and sustain cross-functional partnerships with Brand Marketing, Patient Services, HEOR, Field Medical Directors, Sales, Medical Affairs, and PRC • Report to the Director, US Value & Access and serve as KAM access lead for launch and inline brands
• Undergraduate bachelor’s degree required, ideally in health sciences or business/marketing • At least 12 years of bio/pharmaceutical experience • Previous experience in specialty, payer, key accounts/institutions, and access marketing of at least 3 years preferred • Demonstrated ability to assess organizational capability gaps and training needs across diverse field roles, including KAMs, FAMs, DNAs, and Sales • Knowledge of the institutional healthcare landscape, including IDN and Organized Medical group (OMG) governance structures, P&T committee processes, formulary management, hospital financial management, and operational dynamics of large health systems including EHR systems and pathways • Expertise in market access, reimbursement, and formulary decision-maker marketing in the institutional setting • Ability to integrate policy, clinical, and commercial considerations • Ability to shape functional and brand-level strategy through insight-driven access solutions • Recognized internal subject matter expertise in market access and reimbursement, with a track record of influencing senior and cross-functional stakeholders • New product launch experience in the US required; preference for specialty drug launch • Experience with Pharmacy Benefit products required • MBA or other advanced degree preferred
• Excellent benefits package • Highly competitive benefits
Postuler Maintenant🕒 il y a 11 jours
Field Medical Affairs leader engaging oncology experts and supporting evidence generation for Regeneron’s life-changing medicines. Covering thoracic oncology and pan-tumor priorities across Northern California and neighboring states.
🇺🇸 États-Unis – Télétravail
💵 $176 100 - $287 300 / an
💰 Post-IPO Equity en 2023-10
⏰ Temps Plein
🟠 Senior
👔 Directeur
🦅 Parrain de Visa H1B
🗣️🇺🇸🇬🇧 Anglais requis
🕒 il y a 11 jours
Associate Director advancing Regeneron’s thoracic oncology medical strategy across NY, VT, NH and ME. Engaging KOLs, supporting evidence generation and delivering scientific education.
🇺🇸 États-Unis – Télétravail
💵 $176 100 - $287 300 / an
💰 Post-IPO Equity en 2023-10
⏰ Temps Plein
🟠 Senior
👔 Directeur
🦅 Parrain de Visa H1B
🗣️🇺🇸🇬🇧 Anglais requis
🕒 il y a 11 jours
Senior Director leading consumer insights for ecoATM Gazelle’s device recommerce business. Driving research, analytics, and customer strategy during post-acquisition growth and IPO readiness.
🗣️🇺🇸🇬🇧 Anglais requis
🕒 il y a 11 jours
Associate Director managing admissions counselors for Verto Education’s overseas first-year college programs. Driving enrollment growth, family engagement, and scalable admissions operations.
🇺🇸 États-Unis – Télétravail
💵 $65 000 - $75 000 / an
💰 €28 892 954 Series A - Verto Education en 2021-12
⏰ Temps Plein
🟠 Senior
👔 Directeur
🗣️🇺🇸🇬🇧 Anglais requis
🕒 il y a 11 jours
Senior Director cultivating ultra-high-net-worth donors for HAF’s transformational philanthropic investments. Leading principal-gift strategy, solicitations, donor engagement, and invitation-only events.
🗣️🇺🇸🇬🇧 Anglais requis